Prevalence, types, clinical associations, and determinants of peripheral neuropathy in rheumatoid patients

被引:29
作者
Biswas, Monodeep [1 ]
Chatterjee, Arghya [1 ]
Ghosh, Sudip Kumar [1 ]
Dasgupta, S. [1 ]
Ghosh, Kartik [2 ]
Ganguly, P. K. [2 ]
机构
[1] Calcutta Natl Med Coll, Dept Gen Med, Kolkata, India
[2] Calcutta Natl Med Coll, Dept Neurol, Kolkata, India
关键词
Mononeuritis; neuropathy; peripheral; rheumatoid; sensory; sensorimotor; ARTHRITIS;
D O I
10.4103/0972-2327.85893
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Rheumatoid arthritis is a multi-system autoimmune disorder predominantly involving multiple small and large joints along with certain extra-articular manifestations. The presence of peripheral neuropathy in patients with rheumatoid arthritis contributes significantly to the functional limitation in patients with rheumatoid arthritis. Objectives: To study the prevalence, types, and determinants of peripheral neuropathy in patients with rheumatoid arthritis. Materials and Methods: We studied 74 patients with rheumatoid arthritis of at least 2 year duration for the presence of peripheral neuropathy both clinically and electrophysiologically. The data obtained were entered into a database and continuous variables were analyzed using the Student t test and categorical variables were analyzed using the chi-square test. Results: Peripheral neuropathy was detected in 39.19% (29 out of 74 patients) patients on electrophysiologic testing and 82.76% (24 out of 29 patients) of the patients were asymptomatic. There was significant association between the presence of peripheral neuropathy and disease duration and rheumatoid factor positivity by the latex agglutination method. Sensory neuropathy was the most common form detected. Conclusions: Our study shows that subclinical peripheral neuropathy particularly sensory neuropathy which is not related to disease severity is very common in patients with prolonged disease duration.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 19 条
  • [11] 2-R
  • [12] Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide
    Metzler, C
    Arlt, AC
    Gross, WL
    Brandt, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1798 - 1800
  • [13] MISRA UK, 1999, CLIN NEUROPHYSIOLOGY
  • [14] Nadkar M Y, 2001, J Assoc Physicians India, V49, P217
  • [15] Singh G, 1996, NEUROL INDIA, V44, P85
  • [16] Sivri A, 1999, Electromyogr Clin Neurophysiol, V39, P387
  • [17] The electroneurophysiological evaluation of rheumatoid arthritis patients
    Sivri, A
    Guler-Uysal, F
    [J]. CLINICAL RHEUMATOLOGY, 1998, 17 (05) : 416 - 418
  • [18] Neurotoxic complications of chemotherapy in patients with cancer - Clinical signs and optimal management
    Verstappen, CCP
    Heimans, JJ
    Hoekman, K
    Postma, TJ
    [J]. DRUGS, 2003, 63 (15) : 1549 - 1563
  • [19] WOO JH, 2004, J KOREAN RHEUM ASS, V11, P90